Tourmaline Bio Inc. Financial Flexibility Index
Tourmaline Bio Inc. financial flexibility index. Tourmaline Bio Inc. (TRML) has a Financial Flexibility Index of -2.01x as of June 2025. Free cash flow of $-20.26 Million (operating CF $-20.26 Million minus capex $7.00K) represents -2% of total liabilities ($10.10 Million). See Tourmaline Bio Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tourmaline Bio Inc. (2019–2024)
Financial flexibility index of Tourmaline Bio Inc. from 2019 to 2024. Historical Financial Flexibility Index trend for Tourmaline Bio Inc. across 6 annual periods. Check Tourmaline Bio Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Tourmaline Bio Inc. Financial Flexibility Index by Year (2019–2024)
Tourmaline Bio Inc. financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Tourmaline Bio Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Tourmaline Bio Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.63x | $-77.25 Million | $-77.26 Million | $8.95 Million | ▼ -61.8% |
| 2023 | -5.34x | $-28.02 Million | $-28.08 Million | $5.25 Million | ▼ -10965.4% |
| 2022 | -0.05x | $-1.39 Million | $-6.46 Million | $28.83 Million | ▲ +98.9% |
| 2021 | -4.36x | $-37.55 Million | $-39.99 Million | $8.61 Million | ▼ -16.1% |
| 2020 | -3.76x | $-17.93 Million | $-19.21 Million | $4.77 Million | ▲ +48.3% |
| 2019 | -7.26x | $-17.10 Million | $-17.66 Million | $2.35 Million | — |